Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRA | ARDX | FDMT | ||
| Company | Sierra Oncology Inc | Ardelyx Inc | 4D Molecular Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.98 | 6.53 | 25.04 | ||
| High | 55.17 | 6.57 | 25.27 | ||
| Low | 54.98 | 6.39 | 24.71 | ||
| Last | 54.99 | 6.44 | 24.78 | ||
| Change | +0.02 | -0.11 | -0.52 | ||
| % Change | +0.04% | -1.68% | -2.06% | ||
| Volume | 862,800 | 3,735,200 | 417,500 | ||
| 20-Day Average Volume | 396,690 | 5,111,990 | 676,455 | ||
| Previous Close | 54.97 | 6.55 | 25.30 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.91 | 7.23 | 29.24 | ||
| 20-Day Raw Stochastic | 62.96% | 3.07% | 0.61% | ||
| 20-Day Relative Strength | 77.35% | 34.02% | 41.38% | ||
| Weighted Alpha | +89.10 | +5.30 | -8.79 | ||
| Today's Opinion | 100% Buy | 8% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 8% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/23/22 | -12.62% since 04/11/24 | -10.54% since 04/11/24 | ||
| Low | 54.65 on 06/24/22 | 6.39 on 04/18/24 | 24.71 on 04/18/24 | ||
| High | 55.19 on 06/24/22 | 7.43 on 04/12/24 | 28.43 on 04/15/24 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/27/22 | -17.86% since 03/18/24 | -20.14% since 03/18/24 | ||
| Low | 54.58 on 05/31/22 | 6.39 on 04/18/24 | 24.71 on 04/18/24 | ||
| High | 55.19 on 06/24/22 | 8.25 on 03/19/24 | 36.25 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | +69.83% since 03/30/22 | -19.90% since 01/18/24 | +45.34% since 01/18/24 | ||
| Low | 30.87 on 03/31/22 | 6.39 on 04/18/24 | 16.64 on 01/19/24 | ||
| High | 55.19 on 06/24/22 | 10.13 on 02/12/24 | 36.25 on 03/27/24 | ||
| 6-Month | |||||
| %Chg | +144.40% since 12/30/21 | +64.71% since 10/18/23 | +138.04% since 10/18/23 | ||
| Low | 14.91 on 01/24/22 | 3.40 on 10/23/23 | 9.73 on 11/10/23 | ||
| High | 55.19 on 06/24/22 | 10.13 on 02/12/24 | 36.25 on 03/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,342,801 | 1,524,094 | 1,294,272 | ||
| Shares Outstanding, K | 24,419 | 232,686 | 51,157 | ||
| Annual Sales | 0 | 124,460,000 | 20,720,000 | ||
| Annual Net Income | -94,660,000 | -66,070,000 | -100,840,000 | ||
| Last Quarter Sales | 0 | 34,360,000 | 20,200,000 | ||
| Last Quarter Net Income | -27,930,000 | -28,800,000 | -10,260,000 | ||
| 60-Month Beta | 0.01 | 0.85 | 2.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/06/22 | -0.12 on 02/22/24 | -0.77 on 02/29/24 | ||
| Latest Earnings Date | 08/04/22 | 05/01/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||